Implications for Targeted Therapy: Genomic Profiling of USC Pancreatic Tumors

Eric Faber, MD, PhD, of the University of Minnesota Medical School, discusses his recent study reviewing the genomic profiling of the undifferentiated sarcomatoid carcinoma subtype of pancreatic ductal adenocarcinoma.

Dr. Faber highlights the implications of increased expression of PDCD1LG2, PDCD1, and HAVCR2 in USC PDAC tumors.